-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $8

Benzinga·10/30/2026 23:30:16
Listen to the news
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $10 to $8.